Vetter is investing more than $100 million across its production sites in Germany and the United States to expand and upgrade its facilities. The moves are intended to meet increasing demand from pharma and biopharma customers for filling capacity, as well as keep pace with evolving regulatory requirements.   Two new state-of-the-art filling lines are being designed for Vetter’s Ravensburg South facility. The new lines will fill liquid cartridges and vials, respectively, and join the produ...